key: cord-0856467-t9ejc9n9 authors: Hirschfeld, Cole B.; Shaw, Leslee J.; Williams, Michelle C.; Lahey, Ryan; Villines, Todd C.; Dorbala, Sharmila; Choi, Andrew D.; Shah, Nishant R.; Bluemke, David A.; Berman, Daniel S.; Blankstein, Ron; Ferencik, Maros; Narula, Jagat; Winchester, David; Malkovskiy, Eli; Goebel, Benjamin; Randazzo, Michael J.; Lopez-Mattei, Juan; Parwani, Purvi; Vitola, Joao V.; Cerci, Rodrigo J.; Better, Nathan; Raggi, Paolo; Lu, Bin; Sergienko, Vladimir; Sinitsyn, Valentin; Kudo, Takashi; Nørgaard, Bjarne Linde; Maurovich-Horvat, Pál; Cohen, Yosef A.; Pascual, Thomas N.B.; Pynda, Yaroslav; Dondi, Maurizio; Paez, Diana; Einstein, Andrew J. title: Impact of COVID-19 on Cardiovascular Testing in the United States Versus the Rest of the World: The INCAPS-COVID Study date: 2021-06-16 journal: JACC Cardiovasc Imaging DOI: 10.1016/j.jcmg.2021.03.007 sha: 44a6be94dbf266ea76d9b32bad18aac311c0aed6 doc_id: 856467 cord_uid: t9ejc9n9 OBJECTIVES: This study sought to quantify and compare the decline in volumes of cardiovascular procedures between the United States and non-US institutions during the early phase of the coronavirus disease-2019 (COVID-19) pandemic. BACKGROUND: The COVID-19 pandemic has disrupted the care of many non-COVID-19 illnesses. Reductions in diagnostic cardiovascular testing around the world have led to concerns over the implications of reduced testing for cardiovascular disease (CVD) morbidity and mortality. METHODS: Data were submitted to the INCAPS-COVID (International Atomic Energy Agency Non-Invasive Cardiology Protocols Study of COVID-19), a multinational registry comprising 909 institutions in 108 countries (including 155 facilities in 40 U.S. states), assessing the impact of the COVID-19 pandemic on volumes of diagnostic cardiovascular procedures. Data were obtained for April 2020 and compared with volumes of baseline procedures from March 2019. We compared laboratory characteristics, practices, and procedure volumes between U.S. and non-U.S. facilities and between U.S. geographic regions and identified factors associated with volume reduction in the United States. RESULTS: Reductions in the volumes of procedures in the United States were similar to those in non-U.S. facilities (68% vs. 63%, respectively; p = 0.237), although U.S. facilities reported greater reductions in invasive coronary angiography (69% vs. 53%, respectively; p < 0.001). Significantly more U.S. facilities reported increased use of telehealth and patient screening measures than non-U.S. facilities, such as temperature checks, symptom screenings, and COVID-19 testing. Reductions in volumes of procedures differed between U.S. regions, with larger declines observed in the Northeast (76%) and Midwest (74%) than in the South (62%) and West (44%). Prevalence of COVID-19, staff redeployments, outpatient centers, and urban centers were associated with greater reductions in volume in U.S. facilities in a multivariable analysis. CONCLUSIONS: We observed marked reductions in U.S. cardiovascular testing in the early phase of the pandemic and significant variability between U.S. regions. The association between reductions of volumes and COVID-19 prevalence in the United States highlighted the need for proactive efforts to maintain access to cardiovascular testing in areas most affected by outbreaks of COVID-19 infection. Disruptions in medical care are especially concerning for patients with cardiovascular disease (CVD), which is the leading cause of death for men and women globally. Prior to the pandemic, CVD accounted for 17.9 million deaths worldwide annually (8) . The timely performance of advanced cardiovascular diagnostic tests is essential to the accurate diagnosis, risk stratification, and management of patients with known or suspected CVD (9) (10) (11) . However, diagnostic cardiovascular procedures, as with other elective or nonemergent procedures, have been reduced, delayed, or canceled entirely during the pandemic. We recently reported that worldwide volumes of cardiovascular testing declined by 64% during the early phase of the pandemic (12) , whereas studies from at least 5 countries reported declines of 30% to 40% in invasive coronary angiography (ICA) procedures for acute coronary syndrome (ACS), causing growing concern over the short-and longterm implications of reductions in diagnostic cardiovascular testing on overall CVD morbidity and mortality around the world (13) (14) (15) (16) (17) (18) . At the same time, imaging guidance statements amid the pandemic point to evolving indications for cardiovascular testing to now prioritize acute diagnosis, safety, and decreased downstream resource usage (19) (20) (21) . Furthermore, in addition to the acute cardiovascular complications caused by COVID-19 (22) (23) (24) (25) , an increasing body of evidence is showing possible sustained cardiovascular effects related to the disease (22, 26) . For example, a recent study of patients who recovered from COVID-19 showed that most of those studied had signs consistent with cardiac inflammation (22) , highlighting the need for cardiovascular testing to identify a large at-risk population with new, (12) . In this study, we compared volumes of procedure data between U.S. and non-U.S. institutions and between U.S. regions, and we identified factors associated with diagnostic procedure volume reduction in the U.S. during the early months of the COVID-19 pandemic. U.S. regional analysis included data compiled from external sources, including COVID-19 prevalence data centers. U.S. regional participation was greatest in the South (57 facilities), followed by the Northeast Table 1 ). OPERATIONAL CAPACITY, SAFETY POLICIES, AND STAFFING. Major differences were noted in the responses for operational capacity, safety policies, and staffing between U.S. and non-U.S. facilities ( Table 3) . For example, compared to non-U.S. centers, a greater proportion of U.S. centers reported increased usage of telehealth for direct patient care (90% vs. 65%, Table 4 . In a multivariable analysis, the mean reduction in volumes of procedures during the early phase of the COVID-19 pandemic was 11.5% greater for facilities reporting staff redeployments than those reporting no redeployments (95% confidence interval [CI]: 5.3% to 17.7%; p < 0.001), 12.5% greater for outpatient facilities than for inpatient facilities (95% CI: 6.3% to 18.7%; Although the reported declines in hospital presentations and procedures for ACS are a major cause for concern, additional data are urgently needed to better establish the direct impact of these findings on the morbidity and mortality of CVD around the world. In addition to reductions in ICA procedures, we found that rates of noninvasive cardiovascular procedures also fell sharply during the early pandemic. It Clustered bar graphs display the number of procedures for March 2019 (red), March 2020 (green), and April 2020 (blue) for each test and each U.S. region. TTE was the most represented diagnostic test in the study, followed by stress tests and ICA procedures. The greatest declines in the volume of procedures were seen in stress tests, CCTA, CMR, and CAC. Regional declines were greatest in the Northeast and Midwest, followed by the South and West. PET infection is not shown in the figure due to the small sample size. Abbreviations as in Figure 1 . Hirschfeld et al. This study has several limitations. First, U.S. regional participation in the INCAPS-COVID study was variable, and data collection is prone to potential biases (e.g., volunteer bias or sampling bias). Thus, the extent to which regional data are representative of the true regional changes in cardiovascular testing is un- COVID-19 transforms health care through telemedicine: Evidence from the field Covid-19 and health care's digital revolution Cancer diagnostic delay in the COVID-19 era: what happens next? The impact of the coronavirus disease 2019 outbreak on the attendance of patients with surgical complaints at a tertiary hospital emergency department Reduced rate of hospital admissions for liver-related morbidities during the initial COVID-19 outbreak The COVID-19 pandemic and acute aortic dissections in New York: a matter of public health Where have the ST-segment elevation myocardial infarctions gone during COVID-19 lockdown? World Health Organization Clinical effectiveness of cardiac noninvasive diagnostic testing in patients discharged from the emergency department for chest pain The future of cardiovascular imaging Impact of the publication of appropriate use criteria on usage rates of myocardial perfusion imaging studies in Ontario, Canada: a populationbased study International impact of COVID-19 on the diagnosis of heart disease COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England Population trends in rates of percutaneous coronary revascularization for acute coronary syndromes associated with the COVID-19 outbreak Impact of the COVID-19 pandemic on interventional cardiology activity in Spain Impact of COVID-19 pandemic in cardiology admissions Reduction in ST-segment elevation cardiac catheterization laboratory activations in the United States During COVID-19 pandemic Guidance and best practices for nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic: an information statement from ASNC and SNMMI Society of Cardiovascular Computed Tomography guidance for use of cardiac computed tomography amidst the COVID-19 pandemic endorsed by the American College of Cardiology Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19) Cardiac manifestations of coronavirus disease 2019 (COVID-19): a comprehensive review COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options Cardiovascular implications of the COVID-19 pandemic: a global perspective Cardiac involvement in patients recovered from COVID-2019 identified using magnetic resonance imaging The Statute of the IAEA. Available at Census Regions and Divisions of the United States US Coronavirus Cases and Deaths. USAFacts. org. Available at 2019 State, County, Minor Civil Division, and Incorporated Place FIPS Codes Robust estimation of a location parameter Clinical characteristics of covid-19 in New York City Acute myocardial infarction after laboratory-confirmed influenza infection Impact of the COVID-19 pandemic on emergency department visits-United States Falling stroke rates during COVID-19 pandemic at a comprehensive stroke center Decline in stroke presentations during COVID-19 surge Delayed emergency surgical presentation: impact of corona virus disease (COVID-19) on non-COVID patients Decreased usage of mental health emergency service during the COVID-19 pandemic Utilization and appropriateness of transthoracic echocardiography in response to the COVID-19 pandemic Clinical and economic strategies in outpatient medical care during the COVID-19 pandemic Elective surgery in the time of COVID A primer for clinician deployment to the medicine floors from an epicenter of covid-19 COVID-19 exacerbating inequalities in the US Geographic differences in COVID-19 cases, deaths, and incidence-United States High population densities catalyse the spread of COVID-19 Spatial disparities in coronavirus incidence and mortality in the United States: an ecological analysis as of The COVID-19 pandemic: a call to action to identify and address racial and ethnic disparities Hospitalization and mortality among black patients and white patients with Covid-19 Disparities in cardiovascular disease risk in the United States Urbanization, urbanicity, and health